Peptides DB
Research-centric peptide and protocol reference hub
Study 7 of 19HCG (Human Chorionic Gonadotropin) literatureeuropepmc · Observational2026

Forecasting preterm birth in Kazakhstan through 2050: a cohort-component demographic modeling study.

Preterm birth rates in Kazakhstan are projected to stabilize at around 30,000-33,000 cases annually by 2050, highlighting the need for long-term planning in maternal and neonatal health services.

Read at europepmcAdd to compare

Where it sits

this study against the rest of the hcg (human chorionic gonadotropin) corpus
4
Preclinical
14
Observational · this one
0
Open-label
1
Randomised
0
Reviews

Summary and findings

This study estimated long-term trends in preterm birth in Kazakhstan through 2050 using a cohort-component demographic modeling approach. The analysis utilized national demographic and birth data from 2009 to 2023. The projected annual number of preterm births is expected to stabilize at approximately 30,000-33,000 cases by 2050.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Projected preterm births stabilize at approximately 30,000-33,000 cases annually by 2050.2026

Abstract

The authors’ words, as europepmc supplied them

<h4>Background</h4>Preterm birth remains a major global health challenge, particularly in countries undergoing demographic transition such as Kazakhstan.<h4>Objective</h4>To estimate long-term trends in preterm birth in Kazakhstan through 2050 using a cohort-component demographic modeling approach.<h4>Methods</h4>National demographic and birth data for 2009-2023 were analyzed. A cohort-component model was used to project the population of women aged 15-49 years, accounting for aging, survival, and migration. Future live births and preterm births were estimated under three combined scenarios (optimistic, baseline, and pessimistic), reflecting alternative assumptions regarding fertility and preterm birth proportions. Model performance was evaluated using out-of-sample validation for 2019-2023.<h4>Results</h4>Between 2013 and 2023, the annual number of preterm births ranged from approximately 21,000 to 27,000 cases, with an increase in the proportion observed after 2020. Under the baseline scenario, preterm births are projected to stabilize at approximately 30,000-33,000 cases annually by 2050. Predicted values closely matched observed data, with a mean absolute error of 4 cases and a root mean square error of 4.5 cases.<h4>Conclusions</h4>Preterm birth is expected to remain a sustained public health burden in Kazakhstan through 2050. The projected trends are consistent with demographic changes in the size and age structure of women of reproductive age and should be interpreted as population-level associations rather than direct causal effects. These findings underscore the need for long-term planning of maternal and neonatal health services.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Not reported in abstract.

Elsewhere in the HCG (Human Chorionic Gonadotropin) corpus

DComparison of inhalational methoxyflurane, intranasal fentanyl, and intravenous morphine for treatment of prehospital acute pain in Norway (PreMeFen): a randomised, non-inferiority, three-arm, phase 3 trial.Lancet (London, England) · 2026DPreoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial.Lancet (London, England) · 2026DRussia's health workers complicit in abducting Ukraine's children.Lancet (London, England) · 2026CMale fertility is independent of Enh13 control of <i>Sox9</i> testicular expressionbiorxiv-preprint · 2026 · Not reported in abstract.AnimalCA proteomic signature of oocyte quality from models of varying oocyte developmental competencebiorxiv-preprint · 2026 · log2FC of ± 1 and a p-value ≤ 0.05 between in vivo and in vitro maturation systems.AnimalBPredictive Value of Day 1–4 β-hCG Change for Single-Dose Methotrexate Failure in Tubal Ectopic Pregnancybiorxiv-preprint · 2026 · Median day 1–4 β-hCG percentage change was +26.4% (IQR 10.9–50.8) in the failure group versus -5.9% (IQR -16.8 to +6.6) in the success group (P<0.001).Human